Ledger.Open graph →
SEC Form D · Amendment · filed August 10, 2023

Psy Therapeutics, Inc

Offering
$20.4M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Daniel S. Weiss Pick · Boston, MADirectorDavid S. Barlow · Boston, MAExec · DirectorJerry F. Rosenbaum · Boston, MADirectorJeff S. Troderman · Boston, MAExecWilliam F. Wagner · Boston, MAExecAlan S. Cross · Boston, MADirectorCastle Ridge Ltd · Grand Cayman, Cayman IslandsDirectorB.P. Martiuk · Grand Cayman, Cayman IslandsExec · DirectorGiada De Laurentiis · Los Angeles, CAExecChristopher G. Carter · DALLAS, TXDirectorAdrian De Valois-Franklin · Toronto, Ontario, CanadaDirectorPhillip Mertz · Vancouver, British Columbia, CanadaExecKarl O'Reilly · Grand Cayman, Cayman IslandsExec · DirectorMarc V. Teillon · SAN FRANCISCO, CADirectorStephen A. Foster · SAN FRANCISCO, CADirectorKyle A. Kuczynski · Reno, NVDirectorWilliam P. Vernon · Reno, NVExecJason D. Molt · Reno, NVExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗